Difference of (Ca2+)(i) movements in platelets stimulated by thrombin and TRAP: The involvement of α(IIb)β3-mediated TXA2 synthesis

Thrombosis and Haemostasis

Volumn 79, Issue 6, 1998, Pages 1184-1190

  Aoki, Toshiaki ^a   Tomiyama, Yoshiaki ^b   Honda, Shigenori ^b   Senzaki, Kayoko ^a   Tanaka, Akito ^a   Okubo, Mitsuru ^a   Takahashi, Fumie ^a   Takasugi, Hisashi ^a   Seki, Jiro ^a  

^a ASTELLAS PHARMA INC   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTIBODY; APYRASE; CALCIUM ION; DALTROBAN; GLYCOPROTEIN IB; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOXANE A2; THROMBOXANE B2; ((4 (4 AMIDINOPHENOXY)BUTANOYL)ASPARTYL)VALINE; ((4-(4-AMIDINOPHENOXY)BUTANOYL)ASPARTYL)VALINE; ANTITHROMBOCYTIC AGENT; CALCIUM; DIPEPTIDE; DRUG DERIVATIVE; FIBRINOGEN; FIBRINOGEN RECEPTOR; MONOCLONAL ANTIBODY; PEPTIDE FRAGMENT; PHENYLACETIC ACID DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONAMIDE; THROMBIN RECEPTOR; THROMBIN RECEPTOR PEPTIDE (42 47); THROMBIN RECEPTOR PEPTIDE (42-47); TIROFIBAN; TYROSINE;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOLOGY; ION TRANSPORT; METABOLISM; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION; THROMBOCYTE;

ADENOSINE DIPHOSPHATE; ANTIBODIES, MONOCLONAL; APYRASE; ASPIRIN; BLOOD PLATELETS; CALCIUM; CYCLOOXYGENASE INHIBITORS; DIPEPTIDES; FIBRINOGEN; HUMANS; ION TRANSPORT; PEPTIDE FRAGMENTS; PHENYLACETATES; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; SULFONAMIDES; THROMBIN; THROMBOXANE A2; THROMBOXANE B2; TYROSINE;

EID: 0031595906     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615038     Document Type: Article

References (18)

1. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
2. Chao BH, Kalkunte S, Maraganore JM, Stone SR. Essential groups in synthetic agonist peptides for activation of the platelet thrombin receptor. Biochemistry 1992; 31: 790-6.
3. Huang R-S, Sorisky A, Church WR, Simons ER, Rittenhouse SE. "Thrombin" receptor-directed ligand accounts for activation by thrombin of platelets phospholipase C and accumulation of 3-phosphorylated phosphoinositides. J Biol Chem 1991; 266: 18435-8.
4. Connolly AJ, Ishihara H, Kahn ML, Farese Jr RV, Coughlin SR. Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996; 381: 516-9.
5. Greco NJ, Jamieson GA. High and moderate affinity pathways for α-thrombin-induced platelet activation. PSEBM 1991; 198: 792.
6. MaGowan EB, Detwiler TC. Modified platelet responses to thrombin. Evidence for two types of receptors or coupling mechanisms. J Biol Chem 1986; 261: 739-46.
7. Leung L, Nachman R. Molecular mechanisms of platelet aggregation. Annu Rev Med 1986; 37: 179-86.
8. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988; 71: 831-43.
9. Hawiger J, Timmons S, Kloczewiak M, Strong DD, Doolittle RF. γ and α chains of human fibrinogen possess sites reactive with human platelet receptors. Proc Natl Acad Sci USA 1982; 79: 2086.
10. Plow EF, Pierschbcher MD, Ruoslahti E, Marguerie G, Ginsburg MH. The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA 1985; 82: 8057-61.
11. Aoki T, Cox D, Senzaki K, Seki J, Tanaka A, Takasugi H, Motoyama Y. Anti-platelet and anti-thrombotic effects of FK633, a peptide mimetic GPIIb/IIIa antagonist. Thromb Res 1996; 81: 439-50.
12. Hartnan GD, Egbertson MS, Halczenko W, Laswell WL, Duggan ME, Smith RL, Nayler AM, Manno PD, Lynch RJ, Zhang G, Chang CT-C, Gould RJ. Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitor. J Med Chem 1992; 35: 4640-2.
13. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993; 120: 577-85.
14. 3. Thromb Haemost 1993; 70: 224-8.
15. Calvete JJ. Clues for understanding the structure and function of a prototypic human integrin: The platelet glycoprotein Ilb/IIIa complex. Thromb Haemost 1994; 72: 1-15.
16. Fox J-EB. The platelet cytoskeleton. Thromb Haemost 1993; 70: 884-93.
17. Kouns WC, Fox CF, Lamoreaus WJ, Coons LB, Jennings LK. The effect of glycoprotein IIb-IIIa receptor occupancy on the cytoskeleton of resting and activated platelets. J Biol Chem 1991; 266: 13891-900.
18. FAK in platelets. J Cell Biol 1992; 119: 905-12.